Key result
ACEi/ARBs linked to improved postoperative outcomes vs other antihypertensives in non-cardiac surgery.
Why the study?
The effect of perioperative antihypertensive drugs on mortality and physical function in non-cardiac surgeries remains unclear.
Do ACEi/ARB-based antihypertensive regimens improve surgical outcomes in hypertensive patients undergoing non-cardiac procedures?
Do ACEi/ARB-based antihypertensive regimens improve surgical outcomes in hypertensive patients undergoing non-cardiac procedures?
ACEi/ARB-based antihypertensive regimens are associated with improved surgical outcomes in hypertensive patients undergoing non-cardiac procedures.
Supports perioperative ACEi/ARB continuation in hypertensives; extends observational evidence but leaves causality open pending RCTs.
The effect of perioperative antihypertensive drugs on mortality and physical function in non-cardiac surgeries remains unclear. We aimed to clarify the association between six antihypertensive classes and postoperative outcomes in hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Suzukawa et al. (2026) studied this question. ACEi/ARB-based antihypertensive regimens are associated with improved surgical outcomes in hypertensive patients undergoing non-cardiac procedures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: